One Mind Accelerator

Don Vaughn, Ph.D., is a neuroscientist and entrepreneur whose work in neurotechnology and brain science has been featured by ABC, ESPN, TIME, and The Economist. His TEDx talk, “Neurohacking: Rewiring Your Brain,” has been viewed more than one million times. He earned degrees from @Stanford and a PhD in Neuroscience from @UCLA. @DrDonVaughn is co-founder and CEO of Ampa, advancing breakthroughs in mental health and brain function through neuroscience and artificial intelligence. Ampa was one of 16 companies selected for the 2025 One Mind Accelerator cohort. Since participating, the company has continued scaling its technology, launching a nationwide rollout of its portable, FDA-cleared brain stimulation system following an oversubscribed $8.5M funding round. The One Mind Accelerator supports founders tackling one of the world’s most complex challenges: mental illness, combining small mission-aligned cohorts with direct access to leaders across neuroscience, health systems, venture capital, and industry. With 51 companies in the portfolio, @OMAccelerator is catalyzing a new generation of mental health innovation. Learn more at onemindaccelerator.com #MentalHealth #Innovation #HealthCare #OneMind #Accelerator #MentalHealthAwarenessMonth #MHAM2026 #MentalHealthMonth

Supriya Laknidhi is a healthcare entrepreneur and operator with 15+ years of experience across product, operations, and strategy at some of the country's leading health organizations. She holds a BS from @UMich and an MBA from @NorthwesternU's @KelloggSchool. Her career has spanned roles at @CVSHealth, @Aetna, and The Boston Consulting Group (@BCG), before she went on to serve as COO at Bend Health (@hellobendhealth). Supriya is co-founder and CEO of Cerula Care, the first cancer-focused collaborative behavioral health and care navigation company, seamlessly integrating with oncology practices to provide personalized, virtual-first support to improve health outcomes for people living with cancer. Cerula Care was one of 10 companies selected for the 2024 One Mind Accelerator cohort. Since participating, the company has continued to grow, closing an oversubscribed $3.7 million Seed round led by Esplanade Ventures, with participation from @amplify_cap, @brightedge, @DigiTx_Partners, SpringTime Ventures, and Mike Pykosz, former CEO & co-founder of @OakStreetHealth. The One Mind Accelerator supports founders tackling one of the world’s most complex challenges: mental illness, combining small mission-aligned cohorts with direct access to leaders across neuroscience, health systems, venture capital, and industry. With 51 companies in the portfolio, @OMAccelerator is catalyzing a new generation of mental health innovation. Learn more at onemindaccelerator.com #MentalHealth #Innovation #HealthCare #OneMind #Accelerator #MentalHealthAwarenessMonth #MHAM2026 #MentalHealthMonth

"Looking around that room, I couldn't help but be impressed by what One Mind had built with this accelerator. In just four years they've created what I'm very comfortable naming the world's best mental health accelerator." — Steve Duke, The Hemingway Report We are humbled and honored by this recognition. What started as a bold vision has grown into something truly special, and it only exists because of the founders, partners, mentors, and advocates who show up every single day for this community and for the people mental health innovation is meant to serve. This is what happens when the right people come together around the right mission. ▶︎ Read the full piece: hemingwayau.substack.com/p/a-guild-of-t… #MentalHealth #Innovation #HealthCare #HealthTech #2026OMA #OneMind #Accelerator

Congratulations to Motif Neurotech on receiving FDA approval to begin a feasibility trial for their brain implant for treatment-resistant depression! @motifneuro was part of the 2023 One Mind Accelerator cohort, and watching them reach this milestone is exactly why we do this work. Founded by @JTRobinsonLab, the team has pioneered a remarkable approach: a blueberry-sized device implanted in the skull that delivers targeted brain stimulation, activated simply by wearing a hat. It's the kind of innovation that sounds like science fiction until it isn't. Treatment-resistant depression affects millions of people who have exhausted conventional options. Motif is working to change that, and today, they're one important step closer. ▶︎ Read more via STAT News: statnews.com/2026/04/27/mot… #BrainHealth #MentalHealth #OneMindAccelerator #Neurotech #Innovation #Depression #MedTech

Big news for the behavioral health field AND for the One Mind Accelerator portfolio. 🚀 @ARPA_H has announced the first research teams selected for EVIDENT, a $139 million initiative to transform behavioral health & bring more precise, effective treatments to Americans. We are incredibly proud that 3 One Mind Accelerator companies are among those chosen: Attune Neurosciences, @motifneuro, and @Holobiome_Inc. This recognition is a testament to the groundbreaking science these teams are advancing, and to the urgent need to reimagine how we understand and treat mental health conditions. The future of behavioral health is being built right now. We couldn't be more honored to support the innovators leading the way. ▶︎ Read the full announcement here: arpa-h.gov/news-and-event… #BehavioralHealth #MentalHealth #HealthInnovation #Neuroscience #HealthTech

The program culminated with Demo Day, where all 14 companies took the stage to deliver their final pitches, showcasing the progress, vision, and impact developed over the past 10 weeks. The session closed with remarks from One Mind Co-Founder and Chief Advocacy & Engagement Officer, Brandon Staglin (@BStaglin), recognizing the founders and the journey they’ve undertaken. Following the pitches, guests connected with founders during the Demo Day reception before gathering for a final celebration dinner to close out the 2026 One Mind Accelerator program together. Thank you to all of our founders, speakers, partners, and supporters who made this program possible. We’re incredibly proud of this year’s cohort and the momentum they’ve built. The future of mental health innovation is in strong hands, and we look forward to what comes next. 📸 : Photography by @duffoo_julio #MentalHealth #Innovation #OneMind #Accelerator #DemoDay #healthcarein

The final day of the 2026 One Mind Accelerator closing week marked the culmination of an incredible journey, bringing the cohort together for Demo Day! The day began with breakfast at Baylands Café in Palo Alto, followed by a group walk along the Baylands, offering a moment to connect, recharge, and reflect ahead of the day’s events. The afternoon opened with the Frontiers in Mental Health Summit, featuring remarks from CEO of @OneMindOrg, Kathleen M. Pike, PhD, and a series of forward-looking discussions on the future of the field. From market trends and opportunities with Hemingway Founder @thesteveduke, to emerging insights on metabolic psychiatry, brain-computer interfaces, and neuroadaptive intelligence from Drs. Scott C. Fears (@Amae_Health & @UCLA), @SumnerLN (@merge), @MaryamShanechi (@USC), and @NinaVasan, MD, MBA (@Stanford), the session highlighted the innovation shaping what’s next in mental health.

After lunch, the focus shifted to collaboration across sectors with a Nonprofit Roundtable and meet and greet, fostering dialogue between founders and leaders across the broader mental health ecosystem. The afternoon concluded with a panel discussion on Care Delivery Companies, moderated by Gwill York, Founding Managing Director, Lighthouse Capital Partners. Panelists included: @GolombJosh of @hazelhealthinc, @Stephensmith_14 of @treatmyocd, and @AFriedensohn of @modernhealthco. The discussion highlighted real-world lessons in scaling access, navigating care models, and delivering impact at scale. We wrapped the day with a networking dinner, continuing conversations and strengthening relationships across the cohort and community. Check back tomorrow for a recap on Demo Day, marking the final day of the 2026 program. #MentalHealth #Innovation #OneMind #Accelerator #HealthCare #Startups #TimFerriss #Nonprofit #CareDelivery

Day 2 of the 2026 One Mind Accelerator closing week focused on preparation, storytelling, and connection as founders gear up for Demo Day. After breakfast the day began with a Demo Day dress rehearsal, giving founders the opportunity to refine their pitches and messaging ahead of their final presentations. Late morning featured a special fireside conversation with entrepreneur, investor, and bestselling author, Tim Ferriss (@tferriss). "Take your pain and create your medicine," Ferriss shared, offering insights on performance, resilience, and building with intention.

After lunch, the afternoon focused on storytelling and refinement, with video interviews, exit interviews, and strategic meetings taking place across the cohort, marking an important step in reflecting on progress and planning for what comes next. The day concluded with a networking dinner at Reposado in Palo Alto, continuing conversations and strengthening connections across the community. A strong start to closing week as our founders prepare to take their next big steps forward. Stay tuned for more updates throughout the week! #MentalHealth #Innovation #OneMind #Accelerator #BioTech #HealthCare

The morning continued with a Brand Development Workshop led by @ArielleRSpiegel, @cofertility Co-Founder, who guided founders through sharpening their narratives and positioning as they prepare for the next phase of growth. This was followed by a Founder Story session with @AmitEtkin, MD, PhD, Founder & CEO of @AltoNeuro, who shared insights from his journey building and scaling a neuroscience company.

Closing week of the 2026 One Mind Accelerator kicked off yesterday at the Allied Arts Guild in Menlo Park, CA, bringing the cohort back together to reflect, refine, and prepare for what’s ahead. The day began with breakfast followed by a welcome from the One Mind team, including remarks from One Mind's Chief Innovation Officer, Pushkar Joshi, PhD, CEO Kathleen M. Pike, PhD, and Co-Founder & Chief Advocacy and Engagement Officer Brandon Staglin (@BStaglin), who set the stage for the week ahead and the milestones to come.

Congrats to Metabolic Psychiatry Labs (2025 OMA) & founder @ShebaniMD on the publication of their landmark paper in @Nature! This field-defining review synthesizes a growing body of evidence linking metabolic dysfunction to psychiatric illness, outlines emerging metabolism-based therapeutic strategies, and points to a future where psychiatric care more fully integrates metabolic screening, prevention, & treatment. Read the paper: doi.org/10.1038/s44220… Learn more: businesswire.com/news/home/2026… #OneMindAccelerator #2025OMA #MentalHealthInnovation #MetabolicPsychiatry #BrainHealth #Research

MEET THE 2026 COHORT: ⁠Vitalic Health⁠ ⁠ Vitalic Health is a senior-focused behavioral health solution that provides Medicare Advantage plans & at-risk providers with much-needed engagement & access to geriatric-informed clinical behavioral healthcare for members with polychronic conditions & untreated behavioral health issues. ⁠ ⁠ Data has shown for years that untreated behavioral health exacerbates the costs associated with managing these members as they are 3x more expensive than members without behavioral conditions, and a Medicare Advantage plan’s existing network lacks the ability to outreach & engage these members proactively.⁠ ⁠ Vitalic’s model of care is an 8-12 week episode of care provided virtually by a multidisciplinary team consisting of a consulting geriatric psychiatrist, nurse practitioner, mid-level therapist and coach. In addition to improving the member’s behavioral health scores & member satisfaction, Vitalic’s promise to the Medicare Advantage plan/at-risk provider ⁠is to also show clear reduction in unnecessary utilization of services including emergency department visits & inpatient stays.⁠ ⁠⁠⁠ ▶︎ Learn more at ⁠vitalichealth.co ⁠ ⁠▶︎ Visit our website to learn more about the One Mind Accelerator program and this year's cohort of 14 companies shaping the future of mental health science, innovation, and treatment: onemind.org/news/announcin…⁠ #2026OMA #MentalHealth #Innovation #OneMind #Accelerator #Medicare #MedicareAdvantage #Seniors #Geriatrics

MEET THE 2026 COHORT: ⁠SocialRx⁠ ⁠ SocialRx (formerly Art Pharmacy) is a health technology company advancing social prescribing to address loneliness, mental health, & social isolation at scale. As rates of depression, anxiety, & disconnection continue to rise, traditional clinical models alone are insufficient to meet growing demand. SocialRx complements clinical care by connecting individuals to community-based arts, culture, & nature experiences that improve whole-person health.⁠ ⁠ Through partnerships with health plans, health systems, employers, and universities, SocialRx delivers structured programs that combine a scalable technology platform with human-centered care navigation. Participants are matched to culturally relevant, interest-driven activities in their communities through a national network of trusted local partners. The model is designed to be measurable, cost-effective, & adaptable across populations, geographies, & use cases.⁠ ⁠ SocialRx has paying marquee customers across multiple sectors & is generating growing evidence of impact, including reductions in loneliness, improvements in mental health outcomes, decreases in avoidable emergency department visits, & increased engagement with care and community resources. Outcomes measurement is embedded into program delivery, enabling partners to track impact, quality, & return on investment.⁠ ⁠ Founded on the belief that health is shaped as much by social connection as by medical care, SocialRx is building the infrastructure to integrate social connection into care pathways across the United States. By bridging healthcare & community, the company aims to redefine how mental health support is delivered & scaled, creating a more connected, preventive, & human-centered system of care⁠. ⁠▶︎ Learn more at ⁠socialrx.com ⁠▶︎ Visit our website to learn more about the One Mind Accelerator program and this year's cohort of 14 companies shaping the future of mental health science, innovation, and treatment: onemind.org/news/announcin… #2026OMA #MentalHealth #Innovation #OneMind #Accelerator #HealthTech #Loneliness Y⁠⁠⁠

MEET THE 2026 COHORT: ⁠Radicle Science⁠ ⁠ @radiclescience is a healthtech public benefit corporation on a mission to transform mental wellness by enabling rigorous science at unprecedented speed, scale, & affordability. Since launching in 2021, Radicle Science has become the #1 U.S. generator of rigorous clinical evidence in wellness. ⁠ ⁠ Through a vertically integrated, decentralized, AI-driven model, the company has conducted blinded, randomized, placebo-controlled trials with 80,000+ Americans—more than all FDA drug approval trials combined over the same period. Radicle’s patent-pending Proof-as-a-Service™ platform runs end-to-end automated, gold-standard trials, creating the largest aggregated wellness clinical dataset to date, spanning biomarkers, wearables, digital health measures, behaviors, & demographics.⁠ ⁠ Radicle’s diverse community of “citizen scientists”—over 50% female, 25%+ racial minorities, and 20%+ rural participants—unlocks precision health insights across subpopulations historically invisible to science. These insights have led ⁠to multiple peer-reviewed publications with academic collaborators including Harvard, Hopkins, Yale, UCLA.⁠ ⁠ Partnering across the wellness value chain—including suppliers, manufacturers, brands, & retailers—Radicle drives treatment effectiveness, claims, & real-world impact for mental health. Led by Co-Founders, @drjeffchen & Pelin Thorogood (@PelinT), the 40-person strong Radicle team is redefining how non-prescription mental wellness innovations are developed, validated, & scaled for broad access. ⁠ ⁠⁠⁠ ▶︎ Learn more at ⁠radiclescience.com ⁠ ⁠▶︎ Visit our website to learn more about the One Mind Accelerator program and this year's cohort of 14 companies shaping the future of mental health science, innovation, and treatment: onemind.org/news/announcin…⁠ #2026OMA #MentalHealth #Innovation #OneMind #Accelerator #HealthTech #AI #Wellness

Exciting to see one of our 2026 One Mind Accelerator companies, Vitalic Health, recognized for its innovation and impact. Through its collaboration with VNS Health, Vitalic is helping expand access to geriatric behavioral health care, reaching seniors who are often underserved due to stigma or lack of diagnosis. By combining proactive outreach with specialized, team-based care, this model is not only improving mental health outcomes, but also reducing unnecessary emergency room visits among older adults. This kind of innovation, bridging gaps in access, addressing unmet needs, and improving whole-person care, is exactly what the One Mind Accelerator is designed to support. We’re proud to have Vitalic in our 2026 cohort and to see their work gaining well-deserved attention. Read more: health.usnews.com/health-care/ar… #2026OMA #OneMindAccelerator #MentalHealthInnovation #DigitalHealth #BehavioralHealth #HealthcareInnovation #HealthEquity #Startups #Impact #GeriatricCare

MEET THE 2026 COHORT: @OrbitNeuro ⁠ Orbit is building the most sophisticated models of cognitive states and conditions, enabling precision mental healthcare. State of the art diagnostic and efficacy metrics in mental health all rely on episodic, subjective self reporting, introducing noise, recall bias, and muddled variables in clinical trials and early stage research. ⁠ ⁠ Little to no progress has been made around biomarker development due to hardware bottlenecks. High-resolution imaging methods (e.g. fMRI, PET, ECoG, MEG) are unscalable and scalable methods (e.g. EEG) are low resolution and noisy. ⁠ ⁠ Orbit is collecting unprecedentedly rich neural data-sets, enabled by their novel brain wearable which can achieve fMRI-comparable resolution at scale. This proprietary data collection moat will fuel Orbit’s foundation models.⁠ ⁠ The founding team boasts executives from @BlackrockNeuro_, Fitbit (@MadeByGoogle), & senior staff from @Meta AR Glasses, @Google & @livanova. Orbit is backed by founders & executives from @huggingface, @StabilityAI, @Apple, @Microsoft & @Dropbox. ⁠⁠⁠ ▶︎ Learn more at ⁠orbitneuro.com ⁠ ⁠▶︎ Visit our website to learn more about the One Mind Accelerator program and this year's cohort of 14 companies shaping the future of mental health science, innovation, and treatment: onemind.org/news/announcin… ⁠ #2026OMA #MentalHealth #Innovation #OneMind #Accelerator #Diagnostics #Healthcare

MEET THE 2026 COHORT: ⁠Nosis Health ⁠ @NosisHealth is a digital health company reimagining substance use care as whole-person, long-term health—not short-term crisis management. Traditional treatment focuses on stopping use, often ignoring the biological disruption substance use causes to the brain and body, from metabolism and hormones to sleep, inflammation, & cognition. When biology is overlooked, recovery rests on a fragile foundation. Nosis treats substance use disorder as a chronic condition affecting both mind and body, delivering individualized, longitudinal care that combines addiction medicine, advanced diagnostics, therapy, coaching, & personalized lifestyle interventions. The model addresses the biological & psychological drivers of use together & adapts as members progress. The goal isn’t just sobriety—it’s cognitive clarity, physical resilience, reduced long-term disease risk, & renewed capacity to fully engage in life. Substance use affects the whole person. Care should too. ⁠⁠ ▶︎ Learn more at nosis.health ⁠ ⁠▶︎ Visit our website to learn more about the One Mind Accelerator program and this year's cohort of 14 companies shaping the future of mental health science, innovation, and treatment: onemind.org/news/announcin… #2026OMA #MentalHealth #Innovation #OneMind #Accelerator #SubstanceUseDisorder #Treatment #Healthcare

MEET THE 2026 COHORT: ⁠Neurofundus⁠ ⁠ Neurofundus is building a foundation model for precision psychiatry, powered by deep multimodal patient biology & generative AI.⁠ ⁠ Psychiatric medicine is at a breaking point, affecting over 1.2 billion people globally and costing more than $5 trillion each year. Patients often endure years of trial-and-error treatment, limited therapeutic options, and little biological guidance—constraints that have also slowed the development of new psychiatric drugs.⁠ ⁠ Neurofundus is partnering with @amsterdamumc to access a longitudinal cohort of 3000 patients suffering from major depressive disorder and bipolar disorder to generate trillions of molecular observations across thousands of patients. ⁠ ⁠ This will fuel an expert foundation model to subtype disease, optimize treatment, and accelerate drug discovery. From a GPT-like chat for physicians and researchers to API-driven platforms for pharma, research institutes, and biotech, Neurofundus is ushering in the era of precision psychiatry at scale.⁠ ⁠⁠⁠ ▶︎ Learn more at neurofundus.com ⁠ ⁠▶︎ Visit our website to learn more about the One Mind Accelerator program and this year's cohort of 14 companies shaping the future of mental health science, innovation, and treatment: onemind.org/news/announcin… #2026OMA #MentalHealth #Innovation #OneMind #Accelerator #Psychiatry #Medicine⁠